Tumor necrosis factor-&alpha; mediates JNK activation response to intestinal ischemia-reperfusion injury

doi:10.3748/wjg.v19.i30.4925

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 30

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5834)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

403

HTML

3475

Figures (1-6)

186

Tables (1-1)

153

Sum=4217

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

988

Download

629

Sum=1617

Aug 14, 2013 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 14, 2013; 19(30): 4925-4934
Published online Aug 14, 2013. doi: 10.3748/wjg.v19.i30.4925

Table 1 Inhibition of tumor necrosis factor reduced mucosal injured scoring after intestinal ischemia-reperfusion

Group	Mucosal injured scoring
Group	Jejunum	Ileum
SO rats: pretreated with vehicle	0.0 (0-1)	0.0 (0-1)
I/R rats: pretreated with vehicle	5.0 (4-5)^a	4.5 (4-5)^a
I/R rats: pretreated with PTX	3.0 (2-4)^a^c	3.0 (2-4)^a^c
I/R rats: pretreated with IFX	3.5 (2-4)^a^c	3.0 (2-4)^a^c

Values are expressed as the median (range). Six rats were tested in each group.

^aP < 0.05 vs sham-operated (SO) rats pretreated with vehicle,

^cP < 0.05 vs ischemia-reperfusion (I/R) rats pretreated with vehicle. PTX: Pentoxifylline; IFX: Infliximab.

Citation: Yang Q, Zheng FP, Zhan YS, Tao J, Tan SW, Liu HL, Wu B. Tumor necrosis factor-α mediates JNK activation response to intestinal ischemia-reperfusion injury. World J Gastroenterol 2013; 19(30): 4925-4934
URL: https://www.wjgnet.com/1007-9327/full/v19/i30/4925.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i30.4925